Allevetix Medical

Noninvasive Treatment for Type-2 Diabetes and Obesity

Health Tech & Life Sciences
Non Active, Aug 2025 ceased to operate
Series A Caesarea, Israel Founded 2017
LinkedIn
Last updated 2026-06-18
Total raised
$4.4M
Last: 2018-06
Stage
Series A
Founded
2017
Headcount
1
HQ
Caesarea, Israel
Sector
Health Tech & Life Sciences

About

Allevetix Medical develops innovative medical technology focusing on the treatment of metabolic diseases such as type 2 diabetes, obesity, and nonalcoholic steatohepatitis.

The NobiX System is a nonsurgical, fully reversible, and natural treatment designed to mimic the effects of gastric bypass surgery without any need for cuts, ablations, or permanent changes to the patient's anatomy. It consists of a safe and noninvasive implant that prevents food contact with a section of the small intestine linked to hormone abnormality in the case of metabolic diseases.

Allevetix Medical is a subsidiary of Allium Medical Solutions, whose portfolio includes several companies specializing in the development, manufacture, and intentional marketing of medical products.

Funding history · 2 rounds · $4.4M total

2018-06
Date unknown
$3.5M

Q&A

What is Allevetix Medical's primary focus?
Allevetix Medical develops innovative medical technology for the treatment of metabolic diseases such as type 2 diabetes, obesity, and nonalcoholic steatohepatitis.
What is the NobiX System?
The NobiX System is Allevetix Medical's nonsurgical, fully reversible, and natural treatment designed to mimic the effects of gastric bypass surgery using a noninvasive implant to prevent food contact with a section of the small intestine.
What is the current status of Allevetix Medical?
Allevetix Medical is currently inactive, having ceased operations in August 2025.
When was Allevetix Medical founded?
Allevetix Medical was founded in January 2017.
How many employees does Allevetix Medical have?
Allevetix Medical has 1-10 employees.
What is Allevetix Medical's total funding raised?
Allevetix Medical has raised a total of $4,420,000.
When was Allevetix Medical's last funding round?
Allevetix Medical's last funding round occurred in June 2018, raising $920,000 from Allmed Solutions.
What is Allevetix Medical's current product stage?
Allevetix Medical's product is in the clinical trial stage.

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Technologies
Materials & SubstancesImplants
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B

Highlights

1 Patents

Tags

gastroenterologyobesitynon-invasivemedical-devicesdiabetesmedical-equipment
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)